Enveric Biosciences, Inc.
NasdaqCM ENVB
Enveric Biosciences, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2024
Enveric Biosciences, Inc. Net Cash Used For Investing Activities is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
-
Enveric Biosciences, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 5.51 K, a 100.72% change year over year.
-
Enveric Biosciences, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -767.69 K, a -132.22% change year over year.
-
Enveric Biosciences, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 2.38 M.
Key data
| Date | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure |
|---|
Market news
Loading...
Don’t Miss A Beat
NasdaqCM: ENVB
| CEO | Dr. Joseph Edward Tucker Ph.D. |
| IPO Date | May 4, 2015 |
| Location | United States |
| Headquarters | 4851 Tamiami Trail North |
| Employees | 7 |
| Sector | Healthcare |
| Industries | |
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Key trends
Past 5 years
Similar companies
Zura Bio Limited
USD 1.78
4.09%
StockViz Staff
February 6, 2025
Any question? Send us an email